iSpecimen Inc. Files 8-K on Financials

Ticker: ISPC · Form: 8-K · Filed: 2024-08-06T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

iSpecimen filed an 8-K on Aug 6th, check financials.

AI Summary

On August 6, 2024, iSpecimen Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibits, but does not specify any new material events or significant financial figures within the provided text.

Why It Matters

This filing provides an update on iSpecimen Inc.'s financial status and operational results, which is crucial for investors to assess the company's performance and outlook.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

iSpecimen Inc. (company) — Registrant
August 6, 2024 (date) — Date of earliest event reported
Delaware (jurisdiction) — State of incorporation
001-40501 (identifier) — Commission File Number
27-0480143 (identifier) — IRS Employer Identification No.
450 Bedford Street Lexington, MA 02420 (address) — Principal executive offices
( 781 ) 301-6700 (phone_number) — Registrant's telephone number

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on iSpecimen Inc.'s Results of Operations and Financial Condition, as well as Regulation FD Disclosure and Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on August 6, 2024.

In which state was iSpecimen Inc. incorporated?

iSpecimen Inc. was incorporated in Delaware.

What is the principal executive office address for iSpecimen Inc.?

The principal executive office address for iSpecimen Inc. is 450 Bedford Street, Suite 1010, Lexington, MA 02420.

What is the telephone number for iSpecimen Inc.?

The telephone number for iSpecimen Inc. is (781) 301-6700.

From the Filing

0001104659-24-086130.txt : 20240806 0001104659-24-086130.hdr.sgml : 20240806 20240806090048 ACCESSION NUMBER: 0001104659-24-086130 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 43 CONFORMED PERIOD OF REPORT: 20240806 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240806 DATE AS OF CHANGE: 20240806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241177281 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 8-K 1 tm2420908d1_8k.htm FORM 8-K false 0001558569 0001558569 2024-08-06 2024-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): August 6, 2024   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   450 Bedford Street Lexington , MA 02420 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 2.02. Results of Operations and Financial Condition.   On August 6, 2024, iSpecimen Inc., a Delaware corporation (the “Company”), issued a press release (“Earnings Release”) announcing its financial and operating results for the quarter ended June 30, 2024. A copy of the press release is furnished as  Exhibit 99.1  to this Current Repo